New JAMA study finds inhalers for asthma and COPD generate over 2 million metric tons of carbon emissions annually, ...
LA JOLLA, Calif., October 07, 2025--(BUSINESS WIRE)--AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic ...
AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory diseases, today announced the closing of a $21 ...
Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study — the largest to date quantifying inhaler-related ...
A new study highlights an overlooked contributor to greenhouse gas emissions: inhalers for asthma and chronic obstructive pulmonary disease, or COPD, reports CBS News. Published in the Journal of the ...
Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study - the largest to date quantifying inhaler-related ...
The Wisconsin Department of Justice and the Drug Enforcement Administration are hosting a statewide Drug Take-Back event Saturday, Oct. 25. The event aims to provide a safe and responsible way to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback